FINWIRES · TerminalLIVE
FINWIRES

Research Alert: CFRA Keeps Strong Buy Recommendation On Shares Of Amazon.com, Inc.

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

Ahead of AMZN's Q1 print, we trim our 12-month target to $285 from $296, 30x our 2027 EPS of $9.48 (was $9.87; 2026 to $7.60 from $8.00). While this remains a premium to the ~25x peer average, it implies a three-year PEG of 1.5x vs. 2.0x for peers. Our revised estimates reflect elevated AI investment, with total net capex likely rising 50%+ to roughly $200B (~60% three-year CAGR), with a large portion of these investments monetized in 2027/2028. At this scale of spend, alongside strong demand for AMZN's in-house chips (Trainium2 largely sold out; Trainium3 nearly fully subscribed), strong AWS backlog figures, and expanding power capacity, we have high conviction that AWS growth can accelerate from ~20% in 2025 to the high-20% range in 2026 and the mid-30% range in 2027. Elsewhere, we expect continued retail margin expansion, driven by improved fulfillment efficiencies and strength in high-margin digital ads. Profit growth should improve in 2H 2026 as Amazon Leo costs move from the P&L to the balance sheet.

Related Articles

Asia

Shakti Pumps (India) Invests INR100 Million in EV Mobility Unit

Shakti Pumps (India) (NSE:SHAKTIPUMP, BOM:531431) said it has invested 100 million Indian rupees in its wholly owned subsidiary Shakti EV Mobility by subscribing to 10 million equity shares, according to a Tuesday filing to the Indian stock exchanges.Shares of the company rose 1% in Wednesday's trade.With this, Shakti Pumps' total investment in the EV mobility unit has increased to 650 million Indian rupees, the filing said.The investment is aimed at supporting business expansion of the subsidiary, it added.

$BOM:531431$NSE:SHAKTIPUMP
Asia

Challenger's Fiscal 2026 Q3 Update Missed Consensus Across Key Life Metrics, Jarden Says

Challenger's (ASX:CGF) fiscal 2026 third-quarter update missed consensus across key Life metrics, with FM outflows significantly worse than expected, driven by institutional equity mandate attrition in both Australian and global equities, according to a Tuesday note by Jarden.The firm's redemption of all CGFPC notes on May 25 simplifies the capital structure, reduces the AT1 coupon burden, and is earnings-per-share accretive.Jarden sees balanced risk/reward for Challenger in the future, with catalysts including capital management flexibility from the Australian Prudential Regulation Authority reform, as well as expanding retirement partnerships across superfunds.It lowered its fiscal 2026 sales forecast to reflect weaker institutional fixed-term sales, partially offset by higher retail annuity sales as partnerships come online.The investment firm retained its neutral rating on Challenger and raised the price target to AU$8.70 per share from AU$8.60 per share.

$ASX:CGF
Asia

Proya Cosmetics 2025 Profit Down 4%, Revenue Slips 2%

Proya Cosmetics (SHA:603605) posted 2025 attributable net profit of 1.50 billion yuan, down 3.5% from 1.55 billion yuan the previous year.Earnings per share slid to 3.80 yuan from 3.92 yuan, according to a Wednesday filing with the Shanghai bourse.Operating revenue declined 1.7% year over year to 10.6 billion yuan from 10.8 billion yuan.Shares of the cosmetics maker were up over 1% in recent trade.

$SHA:603605